| Trial ID: | L2308 |
| Source ID: | NCT00886574
|
| Associated Drug: |
Cilostazol
|
| Title: |
Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events
|
| Acronym: |
CAPPA
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Cilostazol|DRUG: Aspirin
|
| Outcome Measures: |
Primary: Maximal and mean intima media thickness (IMT) of both common carotid artery of the cilostazol group in comparison with the aspirin group, every 6 months following randomization, for 48 months | Secondary: Events of the ischemic heart disease, every 12 months following randomization, for 48 months|Events of cerebrovascular disease, every 12 months following randomization, for 48 months|Events of peripheral vascular disease, every 12 months following randomization, for 48 months|Events of hemorrhagic vascular complication, every 12 months following randomization, for 48 months
|
| Sponsor/Collaborators: |
Sponsor: Hanyang University | Collaborators: Ajou University School of Medicine|Kyunghee University Medical Center|Korea University Guro Hospital|Inha University Hospital|Inje University|Hallym University Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
400
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2009-04
|
| Completion Date: |
2014-02
|
| Results First Posted: |
|
| Last Update Posted: |
2010-06-04
|
| Locations: |
Inha University Hospital, In Cheon, Korea, Republic of|Hallym University Hospital, Pyungcheon, Korea, Republic of|Hallym University Hospital, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Kyung hee University Medical Center, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00886574
|
